Kyphon Gains X Stop Spinal Stenosis Treatment Via $725 Mil. St. Francis Deal
This article was originally published in The Gray Sheet
Executive Summary
Kyphon will use its established spinal sales force to drive market adoption of St. Francis Medical's X Stop minimally invasive spinal stenosis treatment after acquiring the company in a deal worth up to $725 mil